Brief: Nucana Presents Favorable Data On Nuc-3373

NuCana

12/09/2022 13:38

Sept 12 (Reuters) - NuCana PLC  NCNA.O :
    * NUCANA PRESENTS FAVORABLE DATA ON NUC-3373 AT THE EUROPEAN
SOCIETY OF MEDICAL ONCOLOGY (ESMO) ANNUAL MEETING 2022
    * NUCANA - NUC-3373 SHOWS PROMISING ANTI-TUMOR ACTIVITY &
SAFETY
WITH OXALIPLATIN (NUFOX) & IRINOTECAN (NUFIRI) IN HEAVILY
PRE-TREATED COLORECTAL CANCER PATIENTS
    * NUCANA PLC - RANDOMIZED STUDY OF NUFIRI VERSUS. FOLFIRI IN
SECOND-LINE COLORECTAL CANCER PATIENTS INITIATED

Source text for Eikon:  ID:nGNX82VYJF 
Further company coverage:  NCNA.O 

 ((reuters.briefs@thomsonreuters.com;))